SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is seeing a significant surge in momentum driven by a deepened partnership with NVIDIA, which integrates its QNX operating system into advanced edge AI systems for industrial and healthcare robotics. The investor community is actively discussing this pivot toward physical AI as a major catalyst for a long-term re-rating, with many hopeful that this software-focused growth strategy will finally distance the company from its legacy hardware narrative.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group is currently trending as investors focus on its strategic pivot toward a capital-efficient, infrastructure-heavy model bolstered by new financial regulatory approvals and high-profile partnerships in the Indian AI market. The community remains divided, with long-term supporters highlighting the massive pipeline and potential for a significant re-rating, while skeptics point to historical governance issues and the company's reliance on large-scale project execution as the primary catalyst for current volatility.

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group (CAR) is currently experiencing an intense, mechanical short squeeze driven by highly concentrated ownership, where two major institutional investors effectively hold over 100% of the float. The community is actively debating the sustainability of this parabolic move, with many traders drawing parallels to historic squeeze events while warning of the severe risks of liquidation once the institutional holders or the company finally exit or dilute their positions.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is rallying as investors digest institutional accumulation and positive industry validation from peer-level activity, driving strong social sentiment and short-squeeze momentum. The community is actively discussing the company's critical role in AI-driven optical infrastructure, potential redomicile plans, and the expectation of upcoming commercial milestones.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is surging following a combination of positive Phase 3 trial results for its psilocybin treatment and a broader sector rally driven by the President's executive order to fast-track psychedelic research. The community is actively discussing the stock's role as a clinical leader, the potential for priority review vouchers, and the ongoing debate regarding short-term volatility versus the long-term potential of the psychedelic medicine market.

$4CHAN is a meme token on the Ethereum Network.   4ChanToken represents a global crypto community that pays homage to the memetic powerhouses of the internet as Pepe, Doge, Shib and all major memes inventor combining them all into one super meme token that is $4CHAN. At its core, 4ChanToken embodies the untamed spirit of the notorious 4chan imageboard, where iconic memes are born, nurtured, and unleashed upon the world. With an unyielding spirit of irreverence and a touch of mischief, $4CHAN has emerged as the darling of meme enthusiasts, internet dwellers, and crypto aficionados alike.   The foundation of 4ChanToken lies in its community. We’ve harnessed the chaotic energy of this digital realm to create a currency that celebrates the power of memetic expression, empowering users to engage in a truly unique and decentralized economy. As a passionate supporter, you’ll join a vibrant ecosystem where dank memes and viral sensations are the lifeblood of commerce. 4ChanToken is more than just a digital currency – it’s the place where memes are born.  The ultimate playground for memelords and crypto degens. Based on the simplicity of holdrs/volume operating a store of value.  The identification of this value is best described as 'digital gold'. That $4chan can ultimately represent a superior store of value relative to all other forms of memecoins by embodying all memes in one token as the factual birthplace of all popular memes.

4Chan

The 4CHAN crypto community is actively rallying around the token's identity as a foundational "source code" or index for meme culture, with discussions centering on its potential as a long-term hedge and a speculative play to flip centralized memecoin market structures. Supporters remain focused on stacking tokens to capitalize on future volatility, framing the project as the "Bitcoin of memecoins" despite ongoing debates and skepticism regarding its market performance and utility.

Fluence Energy, Inc. engages in energy storage products and services, and artificial intelligence-enabled digital applications for renewables and storage. Its storage includes Smartstack, Gridstack Pro, Grisdtack, and Ultrastack. The company was founded on June 21, 2021, and is headquartered in Arlington, VA.

Fluence Energy Inc - Ordinary Shares - Class A

Fluence Energy (FLNC) is currently trending as investors weigh significant long-term growth prospects, supported by a record backlog and surging demand for AI-driven data center power, against short-term volatility and concerns over margin pressure in an evolving battery storage market. The community is actively debating the company's competitive positioning, with many viewing recent price fluctuations as tactical entry points while others closely monitor execution risks and sector-wide capacity imbalances.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

The community is currently gripped by extreme frustration as the Direxion Daily Semiconductor Bear 3X Shares (SOXS) continues to face relentless downward pressure while the underlying semiconductor sector experiences an unprecedented, nearly vertical melt-up. Investors are actively debating whether to capitulate on their bearish positions or double down on their conviction, with many expressing disbelief at the persistent lack of red days and the aggressive, algorithm-driven rally in the broader semi space.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as investors focus on potential leadership shifts at the FDA, specifically the possibility of a former company executive being considered for a key regulatory role. The community remains highly optimistic about the upcoming approval of deramiocel, with many highlighting the stock's strong clinical data and substantial cash position as catalysts for a potential valuation breakout.

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is experiencing extreme volatility and intense community debate after a rapid rally and subsequent collapse, with traders divided between those speculating on a short-squeeze bounce and those labeling the asset a high-risk pump-and-dump scheme. Conversation is currently centered on the project's recent denial of market manipulation, the massive sell-off from all-time highs, and the ongoing investigation into alleged insider supply control.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Jade Biosciences, Inc. (NASDAQ:JBIO) Short Interest Update

Jade Biosciences, Inc. (NASDAQ:JBIO - Get Free Report) saw a large decline in short interest in March. As of March 31st, there was short interest totaling 1,251,725 shares, a decline of 18.5% from...

Jade Biosciences (NASDAQ:JBIO) Stock Price Up 9.7% - Should You Buy?

Jade Biosciences (NASDAQ:JBIO) Stock Price Up 9.7% - Here's What Happened...

Jade Biosciences (NASDAQ:JBIO) Rating Increased to Hold at Zacks Research

Zacks Research raised Jade Biosciences from a "strong sell" rating to a "hold" rating in a report on Wednesday...

Jade Biosciences (NASDAQ:JBIO) Trading Up 7.9% - What's Next?

Jade Biosciences (NASDAQ:JBIO) Stock Price Up 7.9% - What's Next...

867,284 Shares in Jade Biosciences, Inc. $JBIO Bought by Aberdeen Group plc

Aberdeen Group plc acquired a new position in shares of Jade Biosciences, Inc. (NASDAQ:JBIO - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange...

Jade Biosciences, Inc. (NASDAQ:JBIO) Given Average Rating of "Moderate Buy" by Brokerages

Jade Biosciences, Inc. (NASDAQ:JBIO - Get Free Report) has earned an average rating of "Moderate Buy" from the nine research firms that are currently covering the company, Marketbeat Ratings reports...

Jade Biosciences (NASDAQ:JBIO) Sees Unusually-High Trading Volume - Should You Buy?

Jade Biosciences (NASDAQ:JBIO) Sees Strong Trading Volume - What's Next...

HC Wainwright Lowers Earnings Estimates for Jade Biosciences

Jade Biosciences, Inc. (NASDAQ:JBIO - Free Report) - Research analysts at HC Wainwright cut their Q1 2026 EPS estimates for Jade Biosciences in a note issued to investors on Wednesday, March 25th. HC...

Jade Biosciences (NASDAQ:JBIO) Price Target Raised to $35.00 at HC Wainwright

HC Wainwright increased their target price on shares of Jade Biosciences from $25.00 to $35.00 and gave the company a "buy" rating in a research report on Wednesday...

Jade Biosciences (NASDAQ:JBIO) Shares Gap Up After Analyst Upgrade

Jade Biosciences (NASDAQ:JBIO) Shares Gap Up Following Analyst Upgrade...

Jade Biosciences, Inc. is a biotechnology company which engages in the development of drugs for rare cardiopulmonary disease. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension. The company was founded by Benjamin T. Dake on July 27, 2018 and is headquartered in Waltham, MA.

JBIO
Jade Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest JBIO News

JBIOJade Biosciences Inc